DIKUL - logo
E-viri
Celotno besedilo
Recenzirano
  • Safety and efficacy of self...
    Wańha, Wojciech; Mielczarek, Maksymilian; Smolka, Grzegorz; Roleder, Tomasz; Jaguszewski, Miłosz; Ciećwierz, Dariusz; Tomasiewicz, Brunon; Kubler, Piotr; Gorol, Jarosław; Chmielecki, Michał; Bartuś, Stanisław; Navarese, Eliano Pio; Kasprzak, Michał; Sukiennik, Adam; Kubica, Jacek; Lekston, Andrzej; Hawranek, Michał; Reczuch, Krzysztof; Gruchała, Marcin; Ochała, Andrzej; Wojakowski, Wojciech

    Catheterization and cardiovascular interventions, March 1, 2019, 2019-03-01, 2019-03-00, 20190301, Letnik: 93, Številka: 4
    Journal Article

    Background There is a paucity of data on left main (LM) percutaneous coronary intervention (PCI) therapy with dedicated DES platforms. The LM‐STENTYS is a multicenter registry aimed at evaluating clinical outcome after PCI of LM performed with a self‐apposing Stentys DES implantation. Methods The registry consists of 175 consecutive patients treated with Stentys DES implanted to LM. The primary endpoint was the composite of major adverse cardiac and cerebral events (MACCE) defined as cardiac death, myocardial infarction (MI), target lesion revascularization (TLR), and stroke assessed after 1 year. The secondary endpoint was stent thrombosis (ST) at 1 year. Results The median age was 69 years (IQR, 62–78 years). Acute coronary syndrome (ACS) was the presenting diagnosis in 117 (66.9%) patients 74 (63.2%) unstable angina, 31 (26.5%) NSTEMI, 12 (10.3%) STEMI and stable angina (SA) was present in 58 (33.1%) patients. The median SYNTAX score was 23.0 (IQR, 18.7–32.2) in the SA group and 25.0 (IQR, 20.0–30.7) in the ACS group. During 1‐year follow‐up in the SA group two (3.4%) MACCE occurred, both of them were cardiac deaths. In ACS patients there were 19 (16.2%) MACCE 9 (7.7%) cardiac deaths, 11 (9.4%) MIs, 11(9.4%) TLR, 1(0.9%) stroke. Altogether, three (1.7%) cases of acute ST were noted, all of them in ACS subset. Conclusion LM PCI using self‐apposing Stentys DES showed favorable clinical outcomes at 1‐year in patients with SA. Events of ST in the ACS group warrant further research.